CN Patent

CN105534970A — 高浓度奥洛他定眼用组合物

Assigned to Alcon Research LLC · Expires 2016-05-04 · 10y expired

What this patent protects

本发明为眼用组合物，其含有相对高浓度的奥洛他定。典型地，该组合物为眼用水溶液，其含有溶解于该溶液中的相对高浓度的奥洛他定。该组合物优选能够提供眼睛过敏性结膜炎的症状、特别地眼睛过敏性结膜炎的晚期症状的缓解增强。

USPTO Abstract

本发明为眼用组合物，其含有相对高浓度的奥洛他定。典型地，该组合物为眼用水溶液，其含有溶解于该溶液中的相对高浓度的奥洛他定。该组合物优选能够提供眼睛过敏性结膜炎的症状、特别地眼睛过敏性结膜炎的晚期症状的缓解增强。

Drugs covered by this patent

olopatadine-hydrochloride (OLOPATADINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN105534970A
Jurisdiction: CN
Classification: —
Expires: 2016-05-04
Drug substance claim: No
Drug product claim: No
Assignee: Alcon Research LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.